FlashNews:
EUR/USD Price Forecast: Flatlines below 1.1550, while staying bearish under 100-day SMA
Robinhood Ventures Fund II prices $200M IPO at $25 per share
Omeros outlines Q3 2026 interest expense of about $6.5M while advancing $287,000 NTAP for YARTEMLEA
Analysis-Why UK food inflation has yet to surge
AbCellera Biologics prices oversubscribed $200M offering at $9.75/share
Anthropic Said in Talks to Buy Startup Decart for $6 Billion – Bloomberg.com
August 12, 2026 — Trump insists US controls Hormuz, Iran says it could ‘prolong’ war with US – CNN
Coinbase Says Bug Reports Could Triple as AI Adds Security Noise
Why BIP-110 Failed: Flawed Soft Fork Design or Miner Capture?
Paybis Releases New Research Revealing 89% of Crypto Buyers Demand Real-Cost Fee Transparency
VERDO Finalizes Solar-Powered Shared Scooter Development Plan, Partnering with Global Leading Manufacturers to Advance Low-Carbon Mobility Hardware Innovation
WhatsLove AI: AI Video Chat Feature Redefines Authentic Interaction for AI Boyfriend and Girlfriend Companions
Roger Nwatsok Introduces the Invisible Bleed® Framework to Help Organizations Address Hidden Operational Leakage
DataShyre Expands Consent Management for Healthcare With Unified Privacy Automation Platform
Urgent Notice to All XORKETS FX Users
FASAI Expands AI-Powered Fintech Innovation With Research-Driven Tools for Smarter Financial Decision-Making
Wyndham Expands in Singapore with New Days Inn
Staffing Crisis Meets Smart Kitchens: How Chefeon Is Reshaping the Global Restaurant Industry
Veyrion Laxentum Capital Launches VEYRONEX, Advancing Intelligent Asset Management Through an AI-Native Cognitive System
Home » AbCellera Biologics prices oversubscribed $200M offering at $9.75/share
